BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3303480)

  • 21. In vitro sensitivity of Plasmodium falciparum to sulfadoxine and pyrimethamine.
    Klinkaewnarong W; Chongsuphajaisiddhi T; Sabchareon A; Brockelman CR
    Southeast Asian J Trop Med Public Health; 1985 Jun; 16(2):296-301. PubMed ID: 3906921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Resistance of Plasmodium falciparum to fansidar, quinine and tetracycline].
    Alencar FH; Ferraroni JJ; Shrimpton R
    Rev Saude Publica; 1982 Oct; 16(5):299-302. PubMed ID: 6762641
    [No Abstract]   [Full Text] [Related]  

  • 23. Susceptibility of Plasmodium falciparum to pyrimethamine and sulfadoxine/pyrimethamine in Kisumu, Kenya.
    Nguyen-Dinh P; Spencer HC; Chemangey-Masaba S; Churchill FC
    Lancet; 1982 Apr; 1(8276):823-5. PubMed ID: 6122056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrent chloroquine and Fansidar resistance of Plasmodium falciparum: an imported case from Gabon.
    Burchard GD; Winkler E
    Trop Geogr Med; 1988 Jan; 40(1):68-9. PubMed ID: 3289215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chloroquine- and fansidar-resistant falciparum malaria treated with minocycline].
    Ferraroni JJ
    Rev Saude Publica; 1983 Aug; 17(4):328-31. PubMed ID: 6361974
    [No Abstract]   [Full Text] [Related]  

  • 26. [Limits of the efficacy of chloroquine and sulfadoxine-pyrimethamine in Northern Abidjan (Cote d'Ivoire): Combined in vivo and in vitro studies].
    Djaman J; Abouanou S; Basco L; Koné M
    Sante; 2004; 14(4):205-9. PubMed ID: 15745869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of an in vitro microtest for determining the susceptibility of Plasmodium falciparum to sulfadoxine-pyrimethamine: laboratory investigations and field studies in Port-au-Prince, Haiti.
    Nguyen-Dinh P; Payne D; Teklehaimanot A; Zevallos-Ipenza A; Day MM; Duverseau YT
    Bull World Health Organ; 1985; 63(3):585-92. PubMed ID: 3899394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of sulphadoxine/pyrimethamine on gametocytes in falciparum malaria.
    Ittiravivongs A; Vasuvat C; Kongrod S
    Southeast Asian J Trop Med Public Health; 1984 Sep; 15(3):323-5. PubMed ID: 6395351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyrimethamine/sulfadoxine resistant falciparum malaria in East Africa.
    Timmermanns PM; Hess U; Jones ME
    Lancet; 1982 May; 1(8282):1181. PubMed ID: 6122952
    [No Abstract]   [Full Text] [Related]  

  • 30. Pyrimethamine/sulfadoxine resistant falciparum malaria acquired at Dar es Salaam, Tanzania.
    Stahel E; Degrémont A; Lagler U
    Lancet; 1982 May; 1(8281):1118-9. PubMed ID: 6122905
    [No Abstract]   [Full Text] [Related]  

  • 31. Plasmodium falciparum in Haiti: susceptibility to pyrimethamine and sulfadoxine-pyrimethamine.
    Nguyen-Dinh P; Zevallos-Ipenza A; Magloire R
    Bull World Health Organ; 1984; 62(4):623-6. PubMed ID: 6386210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mefloquine-pyrimethamine-sulfadoxine combination delays emergence of mefloquine resistant Plasmodium falciparum in continuous culture.
    Tan-Ariya P; Brockelman CR; Menabandhu C
    Southeast Asian J Trop Med Public Health; 1984 Dec; 15(4):531-5. PubMed ID: 6398918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross resistance of pyrimethamine and sulfadoxine to their related compounds in Plasmodium falciparum.
    Tan-ariya P; Brockelman C
    Southeast Asian J Trop Med Public Health; 1984 Mar; 15(1):7-11. PubMed ID: 6377515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-resistant malaria.
    Lancet; 1981 Nov; 2(8255):1087-8. PubMed ID: 6118530
    [No Abstract]   [Full Text] [Related]  

  • 35. [In vitro sensitivity of Plasmodium falciparum to mefloquine, quinine, amodiaquine, chloroquine, pyronaridine and sulfadoxine/pyrimethamine in south Yunnan].
    Yang H; Yang P; Yang Y
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1994; 12(2):140-2. PubMed ID: 7955166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal concentration of p-aminobenzoic acid and folic acid in the in vitro assay of antifolates against Plasmodium falciparum.
    Tan-ariya P; Brockelman CR; Menabandhu C
    Am J Trop Med Hyg; 1987 Jul; 37(1):42-8. PubMed ID: 3300393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro study assessing the response of plasmodium falciparum malaria to chloroquine, sulfadoxine/pyrimethamine, quinine and mefloquine in Wad Medani District, Sudan.
    Nour BY; Faragalla IA; Saeed OK; Mohamadani AA
    Saudi Med J; 2006 Jun; 27(6):808-12. PubMed ID: 16758040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fansidar resistant Plasmodium falciparum infection in Surinam.
    Oostburg BF; Jozefzoon LM
    Trop Geogr Med; 1983 Sep; 35(3):243-7. PubMed ID: 6359597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new in vitro test for pyrimethamine/sulfadoxine susceptibility of Plasmodium falciparum and its correlation with in vivo resistance in Kenya.
    Spencer HC; Watkins WM; Sixsmith DG; Koech DK; Chulay JD
    Bull World Health Organ; 1984; 62(4):615-21. PubMed ID: 6386209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of drug resistance markers for chloroquine and pyrimethamine-sulfadoxine in Jazan area, Saudi Arabia using PCR and restriction digestion.
    Al Harthi SA
    J Egypt Soc Parasitol; 2007 Apr; 37(1):17-30. PubMed ID: 17580565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.